BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1943468)

  • 1. Comparison of efficacy of cysteamine in depleting prolactin immunoreactivity in different hyperprolactinemic animal models.
    Millard WJ; Romano TM
    Life Sci; 1991; 49(22):1635-42. PubMed ID: 1943468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cysteamine depletes prolactin in young and old hyperprolactinemic rats.
    Simpkins JW; Estes KS; Millard WJ; Sagar SM; Martin JB
    Endocrinology; 1983 May; 112(5):1889-91. PubMed ID: 6832077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible oncostatic action of cysteamine on the pituitary glands of oestrogen-primed hyperprolactinaemic rats.
    Jeitner TM; Oliver JR
    J Endocrinol; 1990 Oct; 127(1):119-27. PubMed ID: 2103572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cysteamine on the lysosomal enzymes of the hyperprolactinaemic rat pituitary.
    Jeitner TM; Oliver JR
    J Endocrinol; 1990 Apr; 125(1):75-80. PubMed ID: 2110966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of pituitary prolactin by cysteamine is due to loss of immunological activity.
    Scammell JG; Dannies PS
    Endocrinology; 1984 Mar; 114(3):712-6. PubMed ID: 6697959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cysteamine on pituitary, MTTW15 tumor, and serum prolactin levels measured by rat lymphoma cell bioassay and radioimmunoassay.
    Parsons JA; Peterson EK; Hartfel MA
    Endocrinology; 1984 May; 114(5):1812-7. PubMed ID: 6714167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of testicular function induced by hyperprolactinemia in the rat.
    Katovich MJ; Cameron DF; Murray FT; Gunsalus GL
    J Androl; 1985; 6(3):179-89. PubMed ID: 4039718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The depletion of plasma prolactin by pantethine in oestrogen-primed hyperprolactinaemic rats.
    Jeitner TM; Oliver JR
    J Endocrinol; 1990 Mar; 124(3):397-402. PubMed ID: 2332716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteamine decreases prolactin responsiveness to thyrotropin-releasing hormone in normal men.
    Copeland PM; Martin JB; Ridgway EC
    Am J Med Sci; 1986 Jan; 291(1):16-9. PubMed ID: 3079953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G proteins in normal rat pituitaries and in prolactin-secreting rat pituitary tumors.
    Bouvier C; Forget H; Lagacé G; Drews R; Sinnett D; Labuda D; Collu R
    Mol Cell Endocrinol; 1991 Jun; 78(1-2):33-44. PubMed ID: 1657658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cysteamine on suckling-induced prolactin secretion in the rat.
    Millard WJ; O'Sullivan D; Riskind PN
    Life Sci; 1987 Nov; 41(20):2255-60. PubMed ID: 3683075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in substance P content at the hypothalamic-pituitary axis during the Wallerian degeneration of peripheral sympathetic neurons after superior cervical ganglionectomy in male rats: effect of hyperprolactinemia.
    Duvilanski BH; Castrillon PO; Cano P; Velardez MO; Esquifino AI
    Exp Biol Med (Maywood); 2001 Jun; 226(6):612-7. PubMed ID: 11395934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of D2 dopamine receptors in dopamine-resistant prolactin-secreting rat pituitary tumors 7315a and MtTW15.
    Bouvier C; Lagacé G; Lafond J; Beauregard G; Potier M; Collu R
    J Neurochem; 1987 Nov; 49(5):1644-50. PubMed ID: 2959753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bromocriptine on serum prolactin levels, pituitary weight and immunoreactive prolactin cells in estradiol-treated ovariectomized rats: an experimental model of estrogen-dependent hyperprolactinemia.
    Ribeiro MF; Spritzer PM; Barbosa-Coutinho LM; Oliveira MC; Pavanato MA; Silva IS; Reis FM
    Braz J Med Biol Res; 1997 Jan; 30(1):113-7. PubMed ID: 9222412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects on male sex behavior and preoptic dopamine neurons of hyperprolactinemia induced by MtTW15 pituitary tumors.
    Kalra PS; Simpkins JW; Luttge WG; Kalra SP
    Endocrinology; 1983 Dec; 113(6):2065-71. PubMed ID: 6641626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteamine causes reduction of prolactin monomers followed by aggregation in the rat pituitary gland.
    Scammell JG; Burrage TG; Eisenfeld AJ; Dannies PS
    Endocrinology; 1985 Jun; 116(6):2347-54. PubMed ID: 3996317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unremitting suppression of the postovariectomy rise in plasma LH by tumor-induced hyperprolactinemia.
    Login IS; Krieg RJ; Kaiser DL; Thorner MO; MacLeod RM
    Neuroendocrinology; 1982 Nov; 35(5):327-32. PubMed ID: 7145024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperprolactinaemia and DNA synthesis in the pituitary gland of the rat.
    Burdman JA; Calabrese MT; MacLeod RM
    J Endocrinol; 1983 Apr; 97(1):65-74. PubMed ID: 6132955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hyperprolactinemia depletes hypothalamic dopamine concentrations in male rats.
    Simpkins JW; Hodson CA; Kalra PS; Kalra SP
    Life Sci; 1982 Apr; 30(16):1349-53. PubMed ID: 7087668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cysteamine induction of the 22K prolactin variant in the rat pituitary.
    Anthony PK; Powers CA
    Neuroendocrinology; 1993 Jan; 57(1):167-76. PubMed ID: 8479612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.